← Eichor
Study identifier: NCT07273773 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Evaluation of the Rigicon Infla10® Inflatable Penile Prosthesis (IPP) for Erectile Dysfunction

Condition: Erectile Dysfunction (ED)  ·  Sponsor: Rigicon, Inc.

PhaseNA
Planned participants182
Who can joinMale, 22 Years to no upper limit
Healthy volunteersNo

About this study

This study evaluates the long-term safety and effectiveness of the Rigicon Infla10® Inflatable Penile Prosthesis in patients with erectile dysfunction. The study follows patients implanted with the Rigicon Infla10® Pulse™ Dynamic Inflatable Penile Prosthesis for up to 3 years after implantation.

This description comes directly from the study's public registry record.

Talk to the study team

Zeynep Tin Konukcu  ·  888-202-9790  ·  clinical@rigicon.com

Always discuss trial participation with your own doctor first.

Locations (7)

Perito UrologyCoral Gables, Florida, United StatesRecruiting
Atlanta Cosmetic UrologyAtlanta, Georgia, United StatesRecruiting
UroPartnersChicago, Illinois, United StatesNot Yet Recruiting
Kramer UrologyHyannis, Massachusetts, United StatesNot Yet Recruiting
Washington Heights UrologyNew York, New York, United StatesRecruiting
Urology Partners of North TexasArlington, Texas, United StatesNot Yet Recruiting
Vitality Urology InstituteHouston, Texas, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07273773